Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) Shares Shorted: Short Interest Up 330.6% in October

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) saw a significant increase in short interest during the month of October. As of October 30th, there was short interest totaling 521 shares, an increase of 330.6% from the October 15th total of 121 shares. Based on an average daily trading volume, of 3,288 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the company are short sold.

Mosaic ImmunoEngineering Stock Performance

Shares of CPMV opened at $0.06 on Friday. The firm has a market cap of $434,400.00, a PE ratio of -0.67 and a beta of -0.87. The company’s 50 day simple moving average is $0.13 and its 200-day simple moving average is $0.45. Mosaic ImmunoEngineering has a 12-month low of $0.05 and a 12-month high of $0.75.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last announced its earnings results on Friday, August 14th. The company reported ($0.02) EPS for the quarter.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc. is a biotechnology company focused on developing immunotherapies designed to stimulate the body’s immune system to fight cancer. Its work has centered on therapeutic approaches intended to improve immune recognition and response against tumors. The company’s development activities have included DNA-based immunotherapy technology, including approaches designed to deliver immune-stimulating genetic material directly to tumor tissue. These therapies are intended to generate localized immune activation while supporting broader systemic anti-tumor responses.